Physician

Yousif Abubakr, MD

According to 2025 Medicare claims, Yousif Abubakr, MD (NPI: 1023013497) practices hematology/oncology in the Jacksonville, FL market, with the plurality of this provider's patient population coming from Duval, FL. This provider's primary affiliated billing organization is CANCER SPECIALISTS, LLC (NPI: 1528323268; TIN: 455523028) and primary practice location at 32256-6932.

Abubakr's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 946 traditional Medicare patients, billed 181,096 HCPCS/CPT codes, and received $2,186,407 in Medicare payments. The top billing code was 78815 (Nuclear medicine study from skull base to mid-thigh with ct scan). Part D data shows 1,040 prescription claims across 148 beneficiaries totaling $2,565,922 in drug costs, led by Verzenio (Abemaciclib). 2023 DME data shows 34 claims. Open Payments data shows 15 records totaling $269. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $4,349,498 to $2,186,407. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,231,485 and ending at $2,565,922. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	7,564	400,576	$4,349,498
2016	7,737	385,918	$4,524,953
2017	6,498	379,857	$3,846,017
2018	1,252	301,470	$3,549,742
2019	1,319	276,400	$3,480,302
2020	1,191	241,763	$2,839,250
2021	1,203	232,940	$3,084,477
2022	899	139,616	$2,079,123
2023	800	151,045	$1,858,321
2024	946	181,096	$2,186,407

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	178	1,235	$1,231,485
2016	185	1,231	$1,315,904
2017	196	1,296	$1,561,597
2018	198	1,155	$1,205,041
2019	174	979	$852,246
2020	152	889	$698,505
2021	161	854	$855,143
2022	156	865	$1,207,627
2023	144	794	$1,122,929
2024	148	1,040	$2,565,922

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	11	120	$9,519
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	11	$210
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	34	$3,860
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
78815	Nuclear medicine study from skull base to mid-thigh with ct scan	208	244	$1,092
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	212	246	$391
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	226	342	$63
36415	Insertion of needle into vein for collection of blood sample	401	1,225	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	398	1,220	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Verzenio	Abemaciclib	25	700	$359,434
Revlimid	Lenalidomide	20	511	$317,875
Pomalyst	Pomalidomide	13	364	$299,704
Ibrance	Palbociclib	20	560	$298,777
Cabometyx	Cabozantinib S-Malate	11	330	$282,142

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	15	$269	Daiichi Sankyo Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Yousif Abubakr, MD?

Tedicare shows public-source Medicare data for Yousif Abubakr, MD (NPI 1023013497), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Yousif Abubakr, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Yousif Abubakr, MD?

Yousif Abubakr, MD is linked to CANCER SPECIALISTS, LLC (billing NPI 1528323268) in the available physician profile data.

Does Yousif Abubakr, MD have Open Payments data?

Yousif Abubakr, MD has 15 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.